Metabotropic glutamate receptors: Physiology, pharmacology, and disease

Annual Review of Pharmacology and Toxicology

Volumn 50, Issue , 2010, Pages 295-322

  Niswender, Colleen M ^a   Conn, P Jeffrey ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allosterism; G protein coupled receptors; Neuromodulation; Synaptic plasticity

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 CHLORO 5 HYDROXYPHENYLGLYCINE; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; BAY 36 7620; EGLUMETAD; JNJ 16259685; LY 487379; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 6; METABOTROPIC RECEPTOR 7; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; RO 67 4853; RO 67 7476; UNCLASSIFIED DRUG; UNINDEXED DRUG; VU 71; YM 298198;

ADDICTION; ALLOSTERISM; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANXIETY; ANXIETY DISORDER; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; DEPRESSION; DRUG PENETRATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FRAGILE X SYNDROME; GASTROESOPHAGEAL REFLUX; GENERALIZED ANXIETY DISORDER; HUMAN; MIGRAINE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVE CELL EXCITABILITY; NERVE DEGENERATION; NEUROMODULATION; NONHUMAN; PANIC; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; CHEMISTRY; DRUG EFFECT; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ALLOSTERIC REGULATION; ALTERNATIVE SPLICING; ANIMALS; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION;

EID: 77949516412     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.011008.145533     Document Type: Review

References (198)

1. Pin JP, Galvez T, Prezeau L. 2003. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol. Ther. 98(3):325-354
2. 3+. Proc. Natl. Acad. Sci. USA 99(5):2660-2665
3. Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, et al. 2000. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407(6807):971-977
4. Muto T, Tsuchiya D, Morikawa A, Jingami H. 2007. Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 104(10):3759-3764
5. Jingami H, Nakanishi S, Morikawa K. 2003. Structure of the metabotropic glutamate receptor. Curr. Opin. Neurobiol. 13(3):271-278
6. Bessis AS, RondardP, Gaven F, BrabetI, Triballeau N, et al. 2002. Closureof the Venus flytrap module of mGlu8 receptor and the activation process: insights from mutations converting antagonists into agonists. Proc. Natl. Acad. Sci. USA 99(17):11097-11102
7. Kuang D, Yao Y, Wang M, Pattabiramann N, Kotra LP, Hampson DR. 2003. Molecular similarities in the ligand binding pockets of an odorant receptor and the metabotropic glutamate receptors. J. Biol. Chem. 278(43):42551-42559
8. Acher FC, Bertrand HO. 2005. Amino acid recognition by Venus flytrap domains is encoded in an 8-residue motif. Biopolymers 80(2-3):357-366
9. 2+-sensing function of the metabotropic glutamate receptors. Science 279(5357):1722-1725
10. Francesconi A, Duvoisin RM. 2004. Divalent cations modulate the activity of metabotropic glutamate receptors. J. Neurosci. Res. 75(4):472-479
11. Rondard P, et al. 2006. Coupling of agonist binding to effector domain activation in metabotropic glutamate-like receptors. J. Biol. Chem. 281(34):24653-24661
12. Gomeza J, Joly C, Kuhn R, Knöpfel T, Bockaert J, Pin J-P. 1996. The second intracellular loop of metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins. J. Biol. Chem. 271(4):2199-2205
13. Pin JP, Joly C, Heinemann SF, Bockaert J. 1994. Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 13(2):342-348
14. Dhami GK, Babwah AV, Sterne-Marr R, Ferguson SSG. 2005. Phosphorylation-independent regulation of metabotropic glutamate receptor 1 signaling requires g protein-coupled receptor kinase 2 binding to the second intracellular loop. J. Biol. Chem. 280(26):24420-24427
15. Hampson DR, Rose EM, Antflick JE. 2008. The structures of metabotropic glutamate receptors. In The Glutamate Receptors, ed. RW Gereau, GT Swanson, pp. 363-386 Totowa, NJ: Human Press
16. Goudet C, Kniazeff J, Vol C, Liu J, Cohen-Gonsaud M, et al. 2004. Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors. Proc. Natl. Acad. Sci. USA 101(1):378-383
17. 2+ requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: involvement of serine 269 of the GABA(B)R1 subunit. Mol. Pharmacol. 57(3):419-426
18. Kammermeier PJ, Yun J. 2005. Activation of metabotropic glutamate receptor 1 dimers requires gluta-mate binding in both subunits. J. Pharmacol. Exp. Ther. 312(2):502-508
19. Kniazeff J, Bessis AS, Maurel D, Ansanay H, Prézeau L, Pin JP. 2004. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol. 11(8):706-713
20. Suzuki Y, Moriyoshi E, Tsuchiya D, Jingami H. 2004. Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1. J. Biol. Chem. 279(34):35526-35534
21. Hermans E, Challiss RA. 2001. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J. 359(Pt 3):465-484
22. Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, Ruan DY. 2007. JNK1 contributes to metabotropic glutamate receptor-dependent long-term depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur. J. Neurosci. 25(2):391-396
23. Saugstad JA, Ingram SL. 2008. Group I metabotropic glutamate receptors (mGluR1 and mGluR5). See Ref. 15, pp. 387-464
24. Page G, Khadir FA, Pain S, Barrier L, Fauconneau B, et al. 2006. Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes. Neurochem. Int. 49(4):413-421
25. Hou L, Klann E. 2004. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24(28):6352-6361
26. Iacovelli L, Bruno V, Salvatore L, Melchiorri D, Gradini R, et al. 2002. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways. J. Neurochem. 82(2):216-223
27. Pin JP, Duvoisin R. 1995. The metabotropic glutamate receptors: structure and functions. Neurophar-macology 34(1):1-26
28. Soloviev MM, Ciruela F, Chan WY, McIlhinney RA. 1999. Identification, cloning and analysis of expression of a new alternatively spliced form of the metabotropic glutamate receptor mGluR1 mRNA1. Biochim. Biophys. Acta 1446(1-2):161-166
29. Joly C, Gomeza J, Brabet I, Curry K, Bockaert J, Pin J-P. 1995. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci. 15(5 Pt 2):3970-3981
30. Minakami R, Yamamoto T, Nakamura K, Sugiyama H. 1994. Molecular cloning and the functional expression of two isoforms of human metabotropic glutamate receptor subtype 5. Biochem. Biophys. Res. Commun. 199(3):1136-1143
31. Sartorius LJ, NagappanG, Lipska BK, LuB, SeiY, et al. 2006. Alternative splicingofhuman metabotropic glutamate receptor 3. J. Neurochem. 96(4):1139-1148
32. Valerio A, FerraboliS, Paterlini M, Spano PF, BarlatiS. 2001. Identificationof novel alternatively-spliced mRNA isoforms of metabotropic glutamate receptor 6 gene in rat and human retina. Gene 262(1-2):99-106
33. Malherbe P, Kratzeisen C, Lundstrom K, Richards JG, Faull RL, Mutel V. 1999. Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Mol. Brain Res. 67(2):201-210
34. Corti C, Restituito S, Rimland M, Brabet I, Corsi M, et al. 1998. Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. Eur. J. Neurosci. 10(12):3629-3641
35. Duvoisin RM, Zhang C, Ramonell K. 1995. A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. J. Neurosci. 15(4):3075-3083
36. Thomsen C, Pekhletski R, Haldeman B, Gilbert TA, O'Hara P, Hampson DR. 1997. Cloning and characterization of a metabotropic glutamate receptor, mGluR4b. Neuropharmacology 36(1):21-30
37. Corti C, Aldegheri L, Somogyi P, Ferraguti F. 2002. Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110(3):403-420
38. Chaudhari N, Landin AM, Roper SD. 2000. A metabotropic glutamate receptor variant functions as a taste receptor. Nat. Neurosci. 3(2):113-119
39. San Gabriel A, Maekawa T, Uneyama H, Torii K. 2009. Metabotropic glutamate receptor type 1 in taste tissue. Am. J. Clin. Nutr. 90:743S-46S
40. San Gabriel A, Uneyama H, Yoshie S, Torii K. 2005. Cloning and characterization of a novel mGluR1 variant from vallate papillae that functions as a receptor for L-glutamate stimuli. Chem. Senses. 30(Suppl 1):i25-26
41. Chaudhari N, Pereira E, Roper SD. 2009. Taste receptors for umami: the case for multiple receptors. Am. J. Clin. Nutr. 90:738S-42S
42. Ehrengruber MU, Kato A, Inokuchi K, Hennou S. 2004. Homer/Vesl proteins and their roles in CNS neurons. Mol. Neurobiol. 29(3):213-227
43. Beneken J, Tu JC, Xiao B, Nuriya M, Yuan JP, et al. 2000. Structure of the Homer EVH1 domain-peptide complex reveals a new twist in polyproline recognition. Neuron 26(1):143-154
44. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, et al. 1998. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21(4):717-726
45. Shiraishi-Yamaguchi Y, Furuichi T. 2007. The Homer family proteins. Genome Biol. 8(2):206
46. Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ. 2005. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J. Neurosci. 25(10):2741-2752
47. Flajolet M, Rakhilin S, Wang H, Starkova N, Nuangchamnong N, et al. 2003. Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3. Proc. Natl. Acad. Sci. USA 100(26):16006-16011
48. Seebahn A, Rose M, Enz R. 2008. RanBPM is expressed in synaptic layers of the mammalian retina and binds to metabotropic glutamate receptors. FEBS Lett. 582(16):2453-2457
49. Rose M, Dutting E, Enz R. 2008. Band 4. 1 proteins are expressed in the retina and interact with both isoforms of the metabotropic glutamate receptor type 8. J. Neurochem. 105:2375-2387
50. Boudin H, Doan Z, Xia J, Shigemoto R, Huganir RL, et al. 2000. Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site. Neuron 28(2):485-497
51. El Far O, Airas J, Wischmeyer E, Nehring RB, Karschin A, Betz H. 2000. Interaction of the C-terminal tail region of the metabotropic glutamate receptor 7 with the protein kinase C substrate PICK1. Eur. J. Neurosci. 12(12):4215-4221
52. El Far O, Betz H. 2002. G-protein-coupled receptors for neurotransmitter amino acids: C-terminal tails, crowded signalosomes. Biochem. J. 365(Pt 2):329-336
53. Dev KK, Nakanishi S, Henley JM. 2001. Regulation of mglu(7) receptors by proteins that interact with the intracellular C-terminus. Trends Pharmacol. Sci. 22(7):355-361
54. Bertaso F, Lill Y, Airas JM, Espeut J, Blahos J, et al. 2006. MacMARCKS interacts with the metabotropic glutamate receptor type 7 and modulatesG protein-mediated constitutive inhibition of calcium channels. J. Neurochem. 99(1):288-298
55. Bertaso F, Zhang C, Scheschonka A, de Bock F, Fontanaud P, et al. 2008. PICK1 uncoupling from mGluR7a causes absence-like seizures. Nat. Neurosci. 11(8):940-948
56. Zhang CS, Bertaso F, Eulenburg V, Lerner-Natoli M, Herin GA, et al. 2008. Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory deficits, and increased susceptibility to pentylenetetrazol. J. Neurosci. 28(34):8604-8614
57. Schoepp DD, Jane DE, Monn JA. 1999. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38(10):1431-1476
58. Annoura H, Fukunaga A, Uesugi M, Tatsuoka T, Horikawa Y. 1996. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino) cyclopropa[b]chromen1a-carboxylates. Bioorg. Med. Chem. Lett. 6:763-766
59. Carroll FY, Stolle A, Beart PM, Voerste A, Brabet I, et al. 2001. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol. 59(5):965-973
60. Lavreysen H, Pereira SN, Leysen JE, Langlois X, Lesage AS. 2004. Metabotropic glutamate 1 receptor distribution and occupancy in the rat brain: a quantitative autoradiographic study using [3H]R214127. Neuropharmacology 46(5):609-619
61. Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, 2007. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1, 2, 3-triazol-4-yl]-N-isopropyl-N-methyl-3, 6-dihydropyridine-1(2H)-carboxamide (FTIDC). J. Pharmacol. Exp. Ther. 321(3):1144-1153
62. Kohara A, Toya T, Tamura S, Watabiki T, Nagakura Y, et al. 2005. Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N, 3-dimethylthiazolo[3, 2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1. J. Pharmacol. Exp. Ther. 315(1):163-169
63. Schkeryantz JM, Kingston AE, Johnson MP. 2007. Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain. J. Med. Chem. 50(11):2563-2568
64. Varney MA, Cosford ND, Jachec C, Rao SP, Sacaan A, et al. 1999. SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J. Pharmacol. Exp. Ther. 290(1):170-181
65. Gasparini F, Lingenhöhl K, Stoehr N, Flor PJ, Heinrich M, et al. 1999. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharma-cology 38(10):1493-1503
66. Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, et al. 2003. 3-[(2-Methyl-1, 3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J. Med. Chem. 46(2):204-206
67. Lea PM 4th, Faden AI. 2006. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS Drug Rev. 12(2):149-166
68. Rodriguez AL, Nong Y, Sekaran NK, Alagille D, Tamagnan GD, Conn J. 2005. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators. Mol. Pharmacol. 68(6):1793-1802
69. Hemstapat K, de Paulis T, Chen Y, Brady AE, Grover VK, et al. 2006. A novel class of positive allosteric modulatorsofmetabotropic glutamate receptor subtype 1interact withasite distinct from thatofnegative allosteric modulators. Mol. Pharmacol. 70(2):616-626
70. Knoflach F, Mutel V, Jolidon S, Kew JNC, Malherbe P, et al. 2001. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc. Natl. Acad. Sci. USA 98(23):13402-13407
71. Conn PJ, Lindsley CW, Jones C. 2008. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 30:25-31
72. Kinney GG, O'Brien JA, Lemaire W, Burno M, Bickel DJ, et al. 2005. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype5hasin vivo activity and antipsychotic-like effects in rat behavioral models. J. Pharmacol. Exp. Ther. 313(1):199-206
73. Liu F, Grauer S, Kelley C, Navarra R, Graf R, et al. 2008. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1, 2, 4]-oxadiazol-5-yl]-piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J. Pharmacol. Exp. Ther. 327(3):827-839
74. Dominguez C, Prieto L, Valli MJ, Massey SM, Bures M, et al. 2005. Methyl substitution of 2-aminobicyclo[3. 1. 0]hexane 2, 6-dicarboxylate (LY354740) determines functional activity at metabotropic glutamate receptors: identification of a subtype selective mGlu2 receptor agonist. J. Med. Chem. 48(10):3605-3612
75. Johnson MP, Schoepp DD. 2008. Group II metabotropic glutamate receptors (mGluR2 and 3). See Ref. 15, pp. 465-488
76. Hemstapat K, Da Costa H, Nong Y, Brady AE, Luo Q, et al. 2007. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther. 322(1):254-264
77. Woltering TJ, Adam G, Wichmann J, Goetschi E, Kew JN, et al. 2008. Synthesis and characterization of 8-ethynyl-1, 3-dihydro-benzo[b][1, 4]diazepin-2-one derivatives. Part 2. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Bioorg. Med. Chem. Lett. 18(3):1091-1095
78. Woltering TJ, Wichmann J, Goetschi E, Adam G, Kew JN, et al. 2008. Synthesis and characterization of 1, 3-dihydro-benzo[b][1, 4]diazepin-2-one derivatives. Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Bioorg. Med. Chem. Lett. 18(8):2725-2729
79. Rowe BA, SchaffhauserH, MoralesS, Lubbers LS, Bonnefous C, et al. 2008. Transpositionofthree amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site. J. Pharmacol. Exp. Ther. 326(1):240-251
80. Schaffhauser H, Rowe BA, Morales A, Chavez-Noriega LE, Yin R, et al. 2003. Pharmacological characterization and identificationofamino acids involvedinthe positive modulationofmetabotropic glutamate receptor subtype 2. Mol. Pharmacol. 64(4):798-810
81. Selvam C, et al. 2007. L-(+)-2-Amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency. J. Med. Chem. 50(19):4656-4664
82. Sibille P, Lopez S, Brabet I, Valenti O, Oueslati N, et al. 2007. Synthesis and biological evaluation of 1-amino-2- phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. J. Med. Chem. 50(15):3585-3595
83. Thomas NK, Wright RA, Howson PA, Kingston AE, Schoepp DD, Jane DE. 2001. (S)-3, 4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40(3):311-318
84. Zhai J, Tian MT, Wang Y, Yu JL, Köster A, et al. 2002. Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors. Neuropharmacology 43(2):223-230
85. Kroona HB, Peterson NL, Koerner JF, Johnson RL. 1991. Synthesis of the 2-amino-4-phosphonobutanoic acid analogues (E)-and (Z)-2-amino-2, 3-methano-4-phosphonobutanoic acid and their evaluation as inhibitors of hippocampal excitatory neurotransmission. J. Med. Chem. 34(5):1692-1699
86. Johansen PA, Chase LA, Sinor AD, Koerner JF, Johnson RL, Robinson MB. 1995. Type4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats. Mol. Pharmacol. 48(1):140-149
87. Ayala JE, Niswender CM, Luo Q, Banko JL, Conn PJ. 2008. Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated. Neuropharmacology 54(5):804-814
88. Niswender CM, Johnson KA, Luo Q, Ayala JE, Kim C, et al. 2008. A novel assay of Gi/o-linked G protein-coupled receptor coupling to potassium channels provides new insights into the pharmacology of the group III metabotropic glutamate receptors. Mol. Pharmacol. 73(4):1213-1224
89. Maj M, Bruno V, Dragic Z, Yamamoto R, Battaglia G, et al. 2003. (-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology 45(7):895-906
90. Marino MJ, Williams DL Jr, O'Brien JA, Valenti O, McDonald TP, et al. 2003. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proc. Natl. Acad. Sci. USA 100(23):13668-13673
91. Mathiesen JM, Svendsen N, Bräuner-Osborne H, Thomsen C, Ramirez MT. 2003. Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. Br. J. Pharmacol. 138(6):1026-1030
92. Niswender CM, Johnson KA, Weaver CD, Jones CK, Xiang Z, et al. 2008. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol. Pharmacol. 74(5):1345-1358
93. Niswender CM, Lebois EP, Luo Q, Kim K, Muchalski H, et al. 2008. Positive allosteric modulatorsof the metabotropic glutamate receptor subtype 4 (mGluR4). Part I. Discovery of pyrazolo[3, 4-d]pyrimidines as novel mGluR4 positive allosteric modulators. Bioorg. Med. Chem. Lett. 18(20):5626-5630
94. MitsukawaK, YamamotoR, OfnerS, NozulakJ, PescottO, et al. 2005. Aselective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc. Natl. Acad. Sci. USA 102(51):18712-18717
95. Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, et al. 2007. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. J. Pharmacol. Exp. Ther. 323(1):147-156
96. Niswender CM, et al. 2008. Permissive antagonism inducedbynegative allosteric modulatorsofmGluR7. Neuropharmacology 55:615 (Abstr.)
97. Kenakin T. 2005. New concepts in drug discovery: collateral efficacy and permissive antagonism. Nat. Rev. Drug Discov. 4(11):919-927
98. Coutinho V, Knopfel T. 2002. Metabotropic glutamate receptors: electrical and chemical signaling properties. Neuroscientist 8(6):551-561
99. Conn PJ, Pin JP. 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:205-237
100. Anwyl R. 1999. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Rev. 29(1):83-120
101. Valenti O, Conn PJ, Marino MJ. 2002. Distinct physiological roles of the G-coupled metabotropic glutamate receptors co-expressed in the same neuronal populations. J. Cell. Physiol. 191(2):125-137
102. Bellone C, Luscher C, Mameli M. 2008. Mechanisms of synaptic depression triggered by metabotropic glutamate receptors. Cell. Mol. Life Sci. 65(18):2913-2923
103. Pinheiro PS, Mulle C. 2008. Presynaptic glutamate receptors: physiological functions and mechanisms of action. Nat. Rev. Neurosci. 9(6):423-436
104. Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ. 2001. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21(16):5925-5934
105. Kullmann DM, Lamsa K. 2008. Roles of distinct glutamate receptors in induction of anti-Hebbian long-term potentiation. J. Physiol. 586(6):1481-1486
106. Aiba A, Chen C, Herrup K, Rosenmund C, Stevens CF, Tonegawa S. 1994. Reduced hippocampal long-term potentiation and context-specific deficit in associative learning in mGluR1 mutant mice. Cell 79(2):365-375
107. Gil-Sanz C, Delgado-Garća JM, Fairén A, Gruart A. 2008. Involvement of the mGluR1 receptor in hippocampal synaptic plasticity and associative learning in behaving mice. Cereb. Cortex 18(7):1653-1663
108. Aiba A, Kano M, Chen C, Stanton ME, Fox DG, et al. 1994. Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell. 79(2):377-388
109. Levenes C, Daniel H, Jaillard D, Conquet F, Crépel F. 1997. Incomplete regression of multiple climbing fibre innervation of cerebellar Purkinje cells in mGLuR1 mutant mice. Neuroreport 8(2):571-574
110. Sachs AJ, Schwendinger JK, Yang AW, Haider NB, Nystuen AM. 2007. The mouse mutants recoil wobbler and nmf373 represent a series of Grm1 mutations. Mamm. Genome 18(11):749-756
111. Brody SA, Conquet F, Geyer MA. 2003. Disruption of prepulse inhibition in mice lacking mGluR1. Eur. J. Neurosci. 18(12):3361-3366
112. Brody SA, Dulawa SC, Conquet F, Geyer MA. 2004. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol. Psychiatry 9(1):35-41
113. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, et al. 2001. Reinforcing and loco-motor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4(9):873-874
114. Bradbury MJ, Campbell U, Giracello D, Chapman D, King C, et al. 2005. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J. Pharmacol. Exp. Ther. 313(1):395-402
115. Muly EC, Mania I, Guo JD, Rainnie DG. 2007. Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution. J. Comp. Neurol. 505(6):682-700
116. Bradley SR, Levey AI, Hersch SM, Conn PJ. 1996. Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies. J. Neurosci. 16(6):2044-2056
117. Koulen P, Brandstatter JH. 2002. Pre-and postsynaptic sites of action of mGluR8a in the mammalian retina. Invest. Ophthalmol. Vis. Sci. 43(6):1933-1940
118. Yokoi M, Kobayashi K, Manabe T, Takahashi T, Sakaguchi I, et al. 1996. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science 273(5275):645-647
119. Higgins GA, Ballard TM, Kew JN, Richards JG, Kemp JA, et al. 2004. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent. Neuropharmacology 46(7):907-917
120. Morishima Y, Miyakawa T, Furuyashiki T, Tanaka Y, Mizuma H, Nakanishi S. 2005. Enhanced cocaine responsiveness and impaired motor coordinationin metabotropic glutamate receptor subtype 2 knockout mice. Proc. Natl. Acad. Sci. USA 102(11):4170-4175
121. Fell MJ, Svensson KA, Johnson BG, Schoepp DD. 2008. Evidence for the roleof metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R, 4S, 5S, 6S)-4-amino-2-sulfonylbicyclo[3. 1. 0]hexane-4, 6-dicarboxylic acid (LY404039). J. Pharmacol. Exp. Ther. 326(1):209-217
122. Woolley ML, Pemberton DJ, Bate S, Corti C, Jones DN. 2008. The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Psychopharmacology (Berl.) 196(3):431-440
123. Corti C, Battaglia G, Molinaro G, Riozzi B, Pittaluga A, et al. 2007. The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegen-eration/neuroprotection. J. Neurosci. 27(31):8297-8308
124. Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, et al. 1993. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J. Biol. Chem. 268(16):11868-11873
125. Dhingra A, Lyubarsky A, Jiang M, Pugh EN Jr, Birnbaumer L, et al. 2000. The light response of ON bipolar neurons requires G[alpha]o. J. Neurosci. 20(24):9053-9058
126. Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, et al. 1995. Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell 80(5):757-765
127. Sugihara H, Inoue T, Nakanishi S, Fukuda Y. 1997. A late ON response remains in visual response of the mGluR6-deficient mouse. Neurosci. Lett. 233(2-3):137-140
128. Lavreysen H, Dautzenberg FM. 2008. Therapeutic potential of group III metabotropic glutamate receptors. Curr. Med. Chem. 15(7):671-684
129. Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, et al. 1999. Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. J. Comp. Neurol. 407(1):33-46
130. Toyono T, Seta Y, Kataoka S, Harada H, Morotomi T, et al. 2002. Expression of the metabotropic glutamate receptor, mGluR4a, in the taste hairs of taste buds in rat gustatory papillae. Arch. Histol. Cytol. 65(1):91-96
131. Uehara S, Muroyama A, EchigoN, MorimotoR, Otsuka M, et al. 2004. Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans. Diabetes 53(4):998-1006
132. Pekhletski R, Gerlai R, Overstreet LS, Huang XP, Agopyan N, et al. 1996. Impaired cerebellar synap-tic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J. Neurosci. 16(20):6364-6373
133. Gerlai R, Roder JC, Hampson DR. 1998. Altered spatial learning and memory in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. Behav. Neurosci. 112(3):525-532
134. Snead OC 3rd, Banerjee PK, Burnham M, Hampson D. 2000. Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J. Neurosci. 20(16):6218-6224
135. Blednov YA, Walker D, Osterndork-Kahanek E, Harris RA. 2004. Mice lacking metabotropic glutamate receptor 4 do not show the motor stimulatory effect of ethanol. Alcohol 34(2-3):251-259
136. Shigemoto R, Kinoshita A, Wada E, Nomura A, Ohishi H, et al. 1997. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17(19):7503-7522
137. Kinoshita A, Shigemoto R, Ohishi H, van der Putten H, Mizuno N. 1998. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J. Comp. Neurol. 393(3):332-352
138. Sansig G, Bushell TJ, Clarke VRJ, Rozov A, Burnashev N, et al. 2001. Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J. Neurosci. 21(22):8734-8745
139. Masugi M, Yokoi M, Shigemoto R, Muguruma K, Watanabe Y, et al. 1999. Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion. J. Neurosci. 19(3):955-963
140. Bushell TJ, Sansig G, Collett VJ, van der Putten H, Collingridge GL. 2002. Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. Sci. World J. 2:730-737
141. Holscher C, SchmidS, Pilz PK, SansigG, van der PuttenH, Plappert CF. 2004. Lackofthe metabotropic glutamate receptor subtype 7selectively impairs short-term working memory but not long-term memory. Behav. Brain. Res. 154(2):473-481
142. Holscher C, Schmid S, Pilz PKD, Sansig G, van der Putten H, Plappert CF. 2005. Lack of the metabotropic glutamate receptor subtype 7 selectively modulates Theta rhythm and working memory. Learn. Mem. 12(5):450-455
143. Goddyn H, Callaerts-Vegh Z, Stroobants S, Dirikx T, Vansteenwegen D, et al. 2008. Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice. Neurobiol. Learn. Mem. 90(1):103-111
144. Callaerts-Vegh Z, Beckers T, Ball SM, Baeyens F, Callaerts F, et al. 2006. Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice. J. Neurosci. 26(24):6573-6582
145. Cryan JF, Kelly PH, Neijt HC, SansigG, Flor PJ, van Der Putten H. 2003. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci. 17(11):2409-2417
146. Stachowicz K, Brañski P, Klak K, van der Putten H, Cryan JF, et al. 2008. Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission. Behav. Pharmacol. 19(5-6):597-603
147. Scherer SW, Soder S, Duvoisin RM, Huizenga JJ, Tsui LC. 1997. The human metabotropic glutamate receptor 8 (GRM8) gene: a disproportionately large gene located at 7q31. 3-q32. 1. Genomics 44(2):232-236
148. Linden AM, Johnson BG, Peters SC, Shannon HE, Tian M, et al. 2002. Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 43(2):251-259
149. Duvoisin RM, Zhang C, Pfankuch TF, O'Connor H, Gayet-Primo J, et al. 2005. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur. J. Neurosci. 22(2):425-436
150. Robbins MJ, Starr KR, Honey A, Soffin EM, Rourke C, et al. 2007. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia. Brain Res. 1152:215-227
151. Tong Q, Ouedraogo R, Kirchgessner AL. 2002. Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets. Am. J. Physiol. Endocrinol. Metab. 282(6):E1324-33
152. Tong Q, Kirchgessner AL. 2003. Localization and function of metabotropic glutamate receptor 8 in the enteric nervous system. Am. J. Physiol. Gastrointest. Liver Physiol. 285(5):G992-1003
153. Pilc A, Chakib S, Nowaka G, Witkin JM. 2008. Mood disorders: regulation by metabotropic glutamate receptors. Biochem. Pharmacol. 75(5):997-1006
154. Swanson CJ, Bures M, Johnson MP, Linden A-M, Monn JA, Schoepp DD. 2005. Metabotropicglutamate receptors as novel targets for anxiety and stress
155. Moghaddam B. 2004. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl.) 174(1):39-44
156. BleakmanD, Alt A, Nisenbaum ES. 2006. Glutamate receptors and pain. Semin. Cell. Dev. Biol. 17(5):592-604
157. Alexander GM, Godwin DW. 2006. Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res. 71(1):1-22
158. Lee HG, Zhu X, O'Neill MJ, Webber K, Casadesus G, et al. 2004. The role of metabotropic glutamate receptors in Alzheimer's disease. Acta. Neurobiol. Exp. (Wars.) 64(1):89-98
159. Conn PJ, Battaglia G, Marino MJ, Nicoletti F,. 2005. Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat. Rev. Neurosci. 6(10):787-798
160. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW. 1995. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355(3):455-469
161. Pecknold JC, McClure DJ, Appeltauer L, Wrzesinski L, Allan T. 1982. Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. J. Clin. Psychopharmacol. 2(2):129-133
162. Porter RH, Jaeschke G, Spooren W, Ballard TM, Büttelmann B, et al. 2005. Fenobam: a clinically validated nonbenzodiazepine anxiolyticisa potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J. Pharmacol. Exp. Ther. 315(2):711-721
163. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27(7):370-377
164. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, et al. 2007. Correction of fragile X syndrome in mice. Neuron 56(6):955-962
165. Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP. 2005. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49(7):1053-1066
166. Slassi A, Isaac M, Edwards L, Minidis A, Wensbo D, et al. 2005. Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. Curr. Top. Med. Chem. 5(9):897-911
167. Lehmann A. 2008. Novel treatments of GERD: focus on the lower esophageal sphincter. Eur. Rev. Med. Pharmacol. Sci. 12(Suppl 1):103-110
168. Keywood C, Wakefield M. 2008. ADX10059, a negative allosteric modulator of mGluR5, demonstrates proof of concept for a role in the management of migraine, in a placebo controlled phase 2A study. Neuropharmacology 55:605
169. Ronesi JA, Huber KM. 2008. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J. Neurosci. 28(2):543-547
170. Garber KB, Visootsak J, Warren ST. 2008. Fragile X syndrome. Eur. J. Hum. Genet. 16(6):666-672
171. O'Brien JA, Lemaire W, Wittmann M, Jacobson MA, Ha SN, et al. 2004. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. J. Pharmacol. Exp. Ther. 309(2):568-577
172. Chen Y, Nong Y, Goudet C, Hemstapat K, de Paulis T, et al. 2007. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses. Mol. Pharmacol. 71(5):1389-1398
173. Darrah JM, Stefani MR, Moghaddam B. 2008. Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. Behav. Pharmacol. 19(3):225-234
174. Schoepp DD, Wright RA, Levine LR, Gaydos B, Potter WZ. 2003. LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress. Stress 6(3):189-197
175. Cartmell J, Monn JA, Schoepp DD. 1999. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J. Pharmacol. Exp. Ther. 291(1):161-170
176. Dunayevich E, Erickson J, Levine L, Landbloom R, Schoepp DD, Tollefson GD. 2008. Efficacy and tol-erability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology 33(10):2549
177. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, et al. 2007. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat. Med. 13(9):1102-1107
178. Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, et al. 2008. Identification of a sero-tonin/glutamate receptor complex implicated in psychosis. Nature 452(7183):93-97
179. Marek GJ, Wright RA, Gewirtz JC, Schoepp DD. 2001. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105(2):379-392
180. Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E. 2007. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Mol. Pharmacol. 72(2):477-484
181. Brady AE, Conn PJ. 2008. Metabotropic glutamate receptor ligands as novel therapeutic agents. See Ref. 15, pp. 529-564
182. Valenti O, Marino MJ, Wittmann M, Lis E, DiLella AG, et al. 2003. Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. J. Neurosci. 23(18):7218-7226
183. Macinnes N, Duty S. 2008. Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo. Eur. J. Pharmacol. 580(1-2):95-99
184. Matsui T, Kita H. 2003. Activationofgroup III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus. Neuroscience 122(3):727-737
185. Wichmann T, DeLong MR. 2003. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv. Neurol. 91:9-18
186. MacInnes N, Messenger MJ, Duty S. 2004. Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat. Br. J. Pharmacol. 141(1):15-22
187. Lopez S, Turle-Lorenzo N, Acher F, De Leonibus E, Mele A, Amalric M. 2007. Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease. J. Neurosci. 27(25):6701-6711
188. Ossowska K, Konieczny J, Wardas J, Pietraszek M, Kuter K, et al. 2007. An influence of ligands of metabotropic glutamate receptor subtypesonparkinsonian- like symptoms and the striatopallidal pathway in rats. Amino Acids 32(2):179-188
189. Konieczny J, Wardas J, Kuter K, Pilc A, Ossowska K. 2007. The influence of group III metabotropic glutamate receptor stimulation by (1S, 3R, 4S)-1-aminocyclo-pentane-1, 3, 4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Neu-roscience 145(2):611-620
190. Amalric M, Lopez S. 2008. Metabotropic glutamate receptors and Parkinson's disease. Neuropharmacology 55:585
191. Reynolds IJ. 2008. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease. Neu-ropharmacology 55:620
192. Ortuno D, Cheng C, Weiss Bergeron MM, Shanker Y. 2008. Identification and characterization of a potent and selective positive allosteric modulator of mGluR4. Presented at Annu. Meet. Soc. Neurosci.
193. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Traficante A, et al. 2006. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J. Neurosci. 26(27):7222-7229
194. Valenti O, Mannaioni G, Seabrook GR, Conn PJ, Marino MJ. 2005. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons. J. Pharmacol. Exp. Ther. 313(3):1296-1304
195. Parelkar NK, Wang JQ. 2008. Upregulation of metabotropic glutamate receptor 8 mRNA expression in the rat forebrain after repeated amphetamine administration. Neurosci. Lett. 433(3):250-254
196. Zhang GC, Vu K, Parelkar NK, Mao LM, Stanford IM, et al. 2008. Acute administration of cocaine reduces metabotropic glutamate receptor 8 protein expression in the rat striatum in vivo. Neurosci. Lett. 449(3):224-227
197. Iacovelli L, Arcella A, Battaglia G, Pazzaglia S, Aronica E, et al. 2006. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J. Neurosci. 26(32):8388-8397
198. Saxe JP, Wu H, Kelly TK, Phelps ME, Sun YE, et al. 2007. A phenotypic small-molecule screen identifies an orphan ligand-receptor pair that regulates neural stem cell differentiation. Chem. Biol. 14(9):1019-1030